Status: Recruiting
Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)
This is a phase II, open-label, non-randomized, single-arm, multicenter study to evaluate the efficacy, safety, and PK of chidamide in patients with R/R PTCL.
Participants needed: 33
Trial details
Phase: Phase 2Age: 20-75Biological sex: AllType: InterventionalSponsor: Great Novel Therapeutics Biotech & Medicals CorporationUpdated: Mar 11, 2025Locations: 5
Eligibility criteria
Histopathological diagnosis, made by the investigator, of the following PTCL sub... [+8]
Females who are pregnant or breastfeeding, or females of childbearing potential... [+16]